| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/24/2003 | WO2003060142A2 Compositions and methods for controlled release |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003059953A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | WO2003059911A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059894A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059881A2 Dna minor groove binding compounds |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059872A1 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins |
| 07/24/2003 | WO2003059834A1 Glass-ceramic composite containing nanoparticles |
| 07/24/2003 | WO2003059384A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | WO2003059381A2 Immunogenic preparations and vaccines on the basis of mrna |
| 07/24/2003 | WO2003059371A1 Anti-bacterial plant compositions |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003059359A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003059347A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
| 07/24/2003 | WO2003059343A2 Drug compositions with indole alkaloids for the treatment of aids |
| 07/24/2003 | WO2003059334A2 Gemcitabine in the treatment of smallpox |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059270A2 Method for reducing morbidity and mortality in critically ill patients |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059263A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003059251A2 Antibody targeting compounds |
| 07/24/2003 | WO2003059193A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003011221A3 PREPARATION AND USE OF α-KETO PHOSPHONATES |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002059300A3 Double-stranded rna-mediated gene suppression |
| 07/24/2003 | WO2002022687A3 Viral chemokine-tumur antigen fusion proteins |
| 07/24/2003 | WO2002018954A3 Inhibition of cmv infection and dissemination |
| 07/24/2003 | WO2002011758A8 Vaccine against the influenza virus and method for producing said virus vaccine |
| 07/24/2003 | US20030140370 Fungal glyoxal oxidases |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139583 Process for preparation of anhydrous azithromycin |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139450 Respiratory syncytial virus |
| 07/24/2003 | US20030139446 Reacting with acid mixed with solvent; salt formation |
| 07/24/2003 | US20030139445 Method for treating retroviral infections |
| 07/24/2003 | US20030139441 Sulfonamido ether substituted imidazoquinolines |
| 07/24/2003 | US20030139436 Stabilized liquid preparation |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139394 Dibenzodiazepine derivatives, their preparation and use |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139377 Bactericides; enzyme inhibitors |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138879 Phosphopantetheinyl transferases and uses thereof |
| 07/24/2003 | US20030138841 Library of novel ''unnatural'' natural products |
| 07/24/2003 | US20030138503 Topical pharmaceutical formulations and methods of treatment |
| 07/24/2003 | US20030138476 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138457 Such as F protein of Paramyxovirus SV5 strain; this recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein; for diagnostic and therapeutic compositions for treatment of diseases |
| 07/24/2003 | US20030138455 Urogential or anorectal transmucosal vaccine delivery system |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138449 Method of administering FimH protein as a vaccine for urinary tract infections |
| 07/24/2003 | US20030138448 An immunogenic conjugate comprising a plurality of deacylated lipopolysaccharide molecules from a gram-negative bacterium covalently linked to gucosamine residue of D.discodideum proteinase 1 |
| 07/24/2003 | US20030138447 Derivatives of choline binding proteins for vaccines |
| 07/24/2003 | US20030138446 Nucleic acid vaccine to protect salmon against piscirickettsiosis salmonis a gramnegative bacteria |
| 07/24/2003 | US20030138445 gp41 antigen |
| 07/24/2003 | US20030138444 Composition and method for treating HIV infection |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138423 Antiinflammation agents and immunotherapy using an enzyme inhibitor; sepsis; antiarthritic and - ulcer agents; colitis; myocarditis; glomerulonephritis; gastrointestinal and nervous system disorders; Crohn's disease; automimmune |
| 07/24/2003 | US20030138421 Human Antibodies specific for interleukin 15 (IL-15) |
| 07/24/2003 | US20030138414 Modulators of methylation for control of bacterial virulence |
| 07/24/2003 | US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 07/24/2003 | US20030138409 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 07/24/2003 | US20030138407 Therapeutic methods for nucleic acid delivery vehicles |